デジタルセラピューティクス：新時代の医療

世界のデジタルセラピューティクスの市場規模は、2022年の40億米ドルから、2027年には139億米ドルに達し、2022年から2027年の予測期間中は28.1%のCAGRを示すと予測されています。

糖尿病の部門は、2022年の11億米ドルから、2027年には39億米ドルに達し、予測期間中は29.1％のCAGRで成長すると予測されています。また、精神疾患・依存症の部門は、2022年の9億6,180万米ドルから、2027年には32億米ドルに達し、予測期間中は27.0％のCAGRで成長すると予測されています。

当レポートでは、世界のデジタルセラピューティクスの市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制・償還環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 市場の見通し

• 市場のスナップショット

第2章 サマリー・ハイライト

第3章 市場概要

• 概要
• デジタルセラピューティクスの進化
• 規制の枠組み
• 償還
• デジタルセラピューティクスの利点
• デジタルセラピューティクスのエコシステム

第4章 市場力学

• 市場に影響を与える要因
• 市場促進要因
• 市場抑制要因
• 機会
• COVID-19の影響

第5章 デジタルセラピューティクス市場：用途別

• 糖尿病
• 精神疾患・依存症
• 心血管疾患
• 神経疾患
• その他

第6章 デジタルセラピューティクス市場：販売チャネル別

• B2B
• B2C

第7章 デジタルセラピューティクス市場：地域別

• 北米
• 欧州
• アジア太平洋
• その他の地域

第8章 競合情勢・市場機会の分析

• 戦略的イニシアチブ
• 競合分析

第9章 企業プロファイル

• AKILI INTERACTIVE LABS INC.
• BIG HEALTH
• CLICK THERAPEUTICS
• HAPPIFY
• OMADA HEALTH INC.
• OREXO AB
• PEAR THERAPEUTICS
• PROPELLER HEALTH
• VOLUNTIS
• WELLDOC

第10章 プロジェクトの範囲・調査手法

List of Tables

• Summary Table A : Global Digital Therapeutics Market, Through 2027
• Table 1 : Examples of Products of Digital Health, Medicine, and Therapeutics
• Table 2 : Digital Therapeutics Products
• Table 3 : Digital Health Apps Globally, 2015-2021
• Table 4 : Global Market for Digital Therapeutics, Through 2027
• Table 5 : Global Digital Therapeutics Market, by Application, Through 2027
• Table 6 : Global Digital Therapeutics Market for Diabetes, by Region, Through 2027
• Table 7 : Global Digital Therapeutics Market for Psychiatric Conditions and Addictions, by Region, Through 2027
• Table 8 : Global Digital Therapeutics Market for Cardiovascular Diseases, by Region, Through 2027
• Table 9 : Global Digital Therapeutics Market for Neurological Diseases, by Region, Through 2027
• Table 10 : Global Digital Therapeutics Market for Other Diseases, by Region, Through 2027
• Table 11 : Global Digital Therapeutics Market, by Sales Channel, Through 2027
• Table 12 : Global Digital Therapeutics Market for B2B Sales Channel, by Region, Through 2027
• Table 13 : Global Digital Therapeutics Market for B2C Sales Channel, by Region, Through 2027
• Table 14 : Global Digital Therapeutics Market, by Region, Through 2027
• Table 15 : Mergers and Acquisitions, 2020-2022

List of Figures

• Summary Figure A : Global Digital Therapeutics Market, 2019-2027
• Figure 1 : Differences between Digital Health, Digital Medicine, and Digital Therapeutics
• Figure 2 : Digital Therapeutics Composition
• Figure 3 : Digital Therapeutics: Key Milestones
• Figure 4 : Digital Therapeutics: Stakeholders Benefits
• Figure 5 : Global Digital Therapeutics Market, by Application, 2019-2027
• Figure 6 : Global Digital Therapeutics Market Shares, by Application, 2021
• Figure 7 : Global Incidence of People Living with Diabetes Aged 20-79 Years, by Region, 2021, 2030, and 2045
• Figure 8 : Global Digital Therapeutics Market for Diabetes, by Region, 2019-2027
• Figure 9 : Global Digital Therapeutics Market for Psychiatric Conditions and Addictions, by Region, 2019-2027
• Figure 10 : Share of Heart Disease Deaths in the U.S., by Disease Type, 2021
• Figure 11 : Global Digital Therapeutics Market for Cardiovascular Diseases, by Region, 2019-2027
• Figure 12 : Global Digital Therapeutics Market for Neurological Diseases, by Region, 2019-2027
• Figure 13 : Global Digital Therapeutics Market for Other Diseases, by Region, 2019-2027
• Figure 14 : Global Digital Therapeutics Market, by Sales Channel, 2019-2027
• Figure 15 : Global Digital Therapeutics Market for B2B Sales Channel, by Region, 2019-2027
• Figure 16 : Global Digital Therapeutics Market for B2C Sales Channel, by Region, 2019-2027
• Figure 17 : Global Digital Therapeutics Market, by Region, 2019-2027
• Figure 18 : Global Digital Therapeutics Market Shares, by Region, 2021
• Figure 19 : Global Digital Therapeutics Market Shares, 2021
• Figure 20 : Orexo: Annual Revenue, 2019-2021
• Figure 21 : Pear Therapeutics: Annual Revenue, 2020 and 2021

Highlights:

The global digital therapeutics market should reach $13.9 billion by 2027 from $4.0 billion in 2022 at a compound annual growth rate (CAGR) of 28.1% for the forecast period of 2022 to 2027.

Diabetes segment of the global digital therapeutics market is expected to grow from $1.1 billion in 2022 to $3.9 billion in 2027 at a CAGR of 29.1% for the forecast period of 2022 to 2027.

Psychiatry (including addiction) segment of the global digital therapeutics market is expected to grow from $961.8 million in 2022 to $3.2 billion in 2027 at a CAGR of 27.0% for the forecast period of 2022 to 2027.

Report Scope:

The current report covers the booming technology of digital therapeutics. It also investigates the current shift in trends away from conventional methods of treatment toward the advanced means offered by digital therapeutics. This report is an update of an earlier report of the same title but focuses on more in-depth information. This report offers a comprehensive analysis of the global digital therapeutics market. Segmentation is based on application and sales channels. Based on application, the market is segmented as diabetes, psychiatric and addiction, neurological, cardiovascular diseases, and others. Based on sales channel the market is segmented as business-to-consumer (B2C) and business-to-business (B2B). The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). For market estimates, data has been provided for 2019, 2020, and 2021 as the base year, 2022, and a forecast for 2027.

The report provides a detailed overview and analysis of the present and future global market for digital therapeutics. Industry growth drivers, restraints, and opportunities are also discussed in detail. The report also provides a competitive landscape, elaborative company profiles, and the impact of COVID-19 on the market. The report focuses on the companies that are developing and encouraging digital therapeutics technology and doing research to develop the technology further.

Report Includes:

• A brief general outlook of the global market for digital therapeutics scenario
• Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Highlights of the current and upcoming market potential for digital therapeutics, and areas of focus to forecast this market into various segments and subsegments
• Updated information on market opportunities and drivers, key shifts and trends, regulations and industry specific challenges, and other factors that will shape this market demand in the coming years (2022-2027)
• Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages
• Review of the technology landscape for digital therapeutics marketplace with emphasis on recently approved products as well as products under development or in different stages of clinical trials
• Profile descriptions of the market leading participants, including Big Health, Happify, Omada Health Inc., Pear Therapeutics and Welldoc

Table of Contents

Chapter 1 Market Outlook

• 1.1 Market Snapshot

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

• 3.1 Overview
• 3.2 Evolution of Digital Therapeutics
• 3.3 Regulatory Framework
• 3.4 Reimbursement
• 3.5 Benefits of Digital Therapeutics
• 3.6 Digital Therapeutics Ecosystem

Chapter 4 Market Dynamics

• 4.1 Factors Affecting the Digital Therapeutics Market
• 4.2 Market Drivers
  • 4.2.1 Increasing Incidence of Chronic Diseases
  • 4.2.2 Increasing Investments
  • 4.2.3 Increasing Preventive Healthcare
  • 4.2.4 Cost-Effective
  • 4.2.5 Rising Use of mHealth Apps and Wearables
• 4.3 Market Restraints
  • 4.3.1 Physician Adoption
  • 4.3.2 Data Privacy and Security Concerns
  • 4.3.3 Regulatory Approval
  • 4.3.4 Reimbursement
• 4.4 Opportunities
  • 4.4.1 Growing Technology Innovations
• 4.5 Impact of COVID-19

Chapter 5 Digital Therapeutics Market by Application

• 5.1 Global Digital Therapeutics Market by Application
• 5.2 Diabetes
• 5.3 Psychiatric Conditions and Addictions
• 5.4 Cardiovascular Diseases
• 5.5 Neurological Diseases
• 5.6 Other Diseases

Chapter 6 Digital Therapeutics Market by Sales Channel

• 6.1 Business-to-Business (B2B)
• 6.2 Business-to-Consumer (B2C)

Chapter 7 Digital Therapeutics Market by Region

• 7.1 North America
• 7.2 Europe
• 7.3 Asia-Pacific
• 7.4 Rest of the World

Chapter 8 Competitive Landscape and Analysis of Market Opportunities

• 8.1 Strategic Initiatives
• 8.2 Competitive Analysis

Chapter 9 Company Profiles

• AKILI INTERACTIVE LABS INC.
• BIG HEALTH
• CLICK THERAPEUTICS
• HAPPIFY
• OMADA HEALTH INC.
• OREXO AB
• PEAR THERAPEUTICS
• PROPELLER HEALTH
• VOLUNTIS
• WELLDOC

Chapter 10 Project Scope and Methodology

• 10.1 Study Goals and Objectives
• 10.2 Reasons for Doing This Study
• 10.3 Scope of Report
• 10.4 What's New in This Update?
• 10.5 Information Sources
• 10.6 Methodology
• 10.7 Geographic Breakdown
• 10.8 Analyst's Credentials
• 10.9 BCC Custom Research
• 10.10 Related BCC Research Reports